The division ranked fourth in the nation among pediatric urology programs according to this year’s US News and World Report survey. Our Urogenital Center, providing care for complex genitourinary conditions, has experienced exponential growth in national and international referrals.
Supporting Cincinnati Children’s strategic goals for clinical expansion, a second multidisciplinary center, the Center for Disorders of Sex Development (DSD), was established in November 2011. The DSD Center provides world-class care for children with congenital chromosomal, gonadal or anatomical variations of sex development. As part of Cincinnati Children’s global initiatives, Shumyle Alam, MD, and Eugene Minevich, MD, traveled to Ecuador; Pramod Reddy, MD, Paul Noh, MD, and Minevich traveled to Israel to perform complex urological surgery.
Division director Pramod Reddy, MD, was honored for his appointment as the first recipient of the Sheldon Wacksman Chair in December 2011. The Division has participated in AILS (Accelerated Improvement Leaders Systems) and is developing care processes and outcomes for three chronic urological conditions: posterior urethral valves (PUV), anorectal malformation (ARM) and neurogenic bladder (NGB). The division's focus on care integration has led the creation of the first-of-its-kind patient registry for patients with PUV.
Research and Fellowship Program
Our faculty leads several significant research projects and serves in a variety of national leadership roles. The basic science lab directed by Pramod Reddy, MD is focused on the relationship between the CNS and the lower urinary tract and how stress can induce changes in bladder function and morphology. Reddy heads a phase 3 clinical trial to evaluate darifenacin as a treatment for neurogenic detrusor overactivity.
William Robert DeFoor Jr., MD, is the principal investigator on a subcontract for the NIH clinical trial, “Randomized intervention for children with vesicoureteral reflux (RIVUR).” DeFoor is evaluating the use of Deflux for VUR patients receiving endoscopic correction.
Paul Noh, MD, is investigating the use of oxybutynin chloride topical gel for the treatment of detrusor overactivity associated with neurological conditions in pediatric patients. DeFoor and Minevich are instituting a randomized controlled trial of patient outcomes comparing low-friction hydrophilic catheters versus standard urethral catheters in children with neuropathic bladder on clean intermittent catheterization.
Elizabeth Jackson, MD, is implementing a study, “Nocturnal Enuresis: Comparison of Buzzer and Voice Alarms on the Rate of Resolution of Bedwetting.”